You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Patent Applications for GIVINOSTAT HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


US Patent Applications for GIVINOSTAT HYDROCHLORIDE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Get Started Free 8,217,079 METHOD FOR TREATING PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES 2010-03-26 Patented Case 2012-06-20
⤷  Get Started Free ⤷  Get Started Free Use of histone deacetylase inhibitors for the care of Philadephia-negative myeloproliferative syndromes 2011-03-25 Abandoned -- Failure to Respond to an Office Action 2014-03-20
⤷  Get Started Free 8,637,702 DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS 2012-04-11 Patented Case 2014-01-08
⤷  Get Started Free 9,522,127 USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES 2013-10-07 Patented Case 2016-11-30
⤷  Get Started Free ⤷  Get Started Free DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTHALEN-2-YL-METHYL]-AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY 2014-07-28 Publications -- Issue Fee Payment Verified 2016-07-14
⤷  Get Started Free ⤷  Get Started Free DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTHALEN-2-YL-METHYL]-AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY 2016-07-13 Non Final Action Mailed 2017-03-14
⤷  Get Started Free ⤷  Get Started Free USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES 2016-11-09 Docketed New Case - Ready for Examination 2017-10-26
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.